Stay updated on Intratumoral Cavrotolimod With PD-1 Blockade Clinical Trial
Sign up to get notified when there's something new on the Intratumoral Cavrotolimod With PD-1 Blockade Clinical Trial page.

Latest updates to the Intratumoral Cavrotolimod With PD-1 Blockade Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedAdded Cutaneous neuroendocrine carcinoma as a related MeSH term and added a Resources link to the Genetic and Rare Diseases Information Center.SummaryDifference0.1%

- Check16 days agoNo Change Detected
- Check24 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

- Check31 days agoChange DetectedWebsite revision updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check59 days agoChange DetectedAdded Revision: v3.4.2; deleted a government funding status notice and Revision: v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check67 days agoChange DetectedAdded a government funding lapse notice and updated the page revision from v3.4.0 to v3.4.1. These changes do not affect study details or outcomes.SummaryDifference0.3%

- Check74 days agoChange DetectedAdded a 'Show glossary' option to the page. Updated metadata/labels: capitalization of 'Last Update Submitted that Met QC Criteria', the footer now displays 'No FEAR Act Data', and the site revision is updated to 'v3.4.0'.SummaryDifference0.2%

Stay in the know with updates to Intratumoral Cavrotolimod With PD-1 Blockade Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Intratumoral Cavrotolimod With PD-1 Blockade Clinical Trial page.